Company profile for Calidi Biotherapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Calidi Biotherapeutics is a clinical-stage immuno-oncology company with proprietary technology that is revolutionizing the utilization of oncolytic viruses through an allogeneic cell-based delivery system. Calidi Biotherapeutics is advancing this potent stem cell and oncolytic virus (SN-V1c-vaccinia virus) combination for use in multiple difficult-to-treat oncology indications. Our team is also developing a universal cell del...
Calidi Biotherapeutics is a clinical-stage immuno-oncology company with proprietary technology that is revolutionizing the utilization of oncolytic viruses through an allogeneic cell-based delivery system. Calidi Biotherapeutics is advancing this potent stem cell and oncolytic virus (SN-V1c-vaccinia virus) combination for use in multiple difficult-to-treat oncology indications. Our team is also developing a universal cell delivery system to protect, amplify and potentiate oncolytic viruses currently in development.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
10210 Campus Point Drive Suite 150 San Diego, CA 92121
Telephone
Telephone
(858) 794-9600
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/17/3189047/0/en/Calidi-Biotherapeutics-Announces-Exclusive-Live-Investor-Webinar-and-Q-A-Session-on-November-19-2025.html

GLOBENEWSWIRE
17 Nov 2025

https://www.globenewswire.com/news-release/2025/11/13/3187871/0/en/Calidi-Biotherapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Recent-Operational-Highlights.html

GLOBENEWSWIRE
13 Nov 2025

https://www.globenewswire.com/news-release/2025/11/10/3184495/0/en/Calidi-Biotherapeutics-Presents-New-Data-on-its-Therapeutic-Lead-CLD-401-at-the-2025-SITC-Annual-Meeting-and-Holds-Its-First-Investor-Day-at-SITC.html

GLOBENEWSWIRE
10 Nov 2025

https://www.globenewswire.com/news-release/2025/11/04/3180247/0/en/Calidi-Biotherapeutics-Announces-Investor-Event-to-be-Held-on-Friday-November-7th-at-the-2025-SITC-Annual-Meeting.html

GLOBENEWSWIRE
04 Nov 2025

https://www.prnewswire.com/news-releases/matica-bio-a-cdmo-leader-in-oncolytic-virus-manufacturing-partners-with-calidi-biotherapeutics-to-advance-calidis-project-toward-ind-302600781.html

PR NEWSWIRE
03 Nov 2025

https://www.globenewswire.com/news-release/2025/10/30/3177358/0/en/Calidi-Biotherapeutics-Announces-New-Data-to-be-Presented-on-its-Therapeutic-Lead-CLD-401-at-the-2025-SITC-Annual-Meeting.html

GLOBENEWSWIRE
30 Oct 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty